Analyst Insights
Featured in The Science Advisory Board: How is the pharma-AI partnership landscape changing?
By Ulrik Kristensen, PhD, The Science Advisory Board contributing writer - January 13, 2021: 2020 was a great year for artificial intelligence (AI) in drug development, where the total investment in the industry hit $9.2 billion and many partnerships between AI specialists and the pharmaceutical industry were formed. 2021 may ...
Charles River Acquired Distributed Bio – Here’s What it Means for the AI Ecosystem
2020 was a great year for AI in drug development where the total investment in the industry hit $9.2B and many partnerships between AI specialists and the pharmaceutical industry were formed. 2021 may prove to be just as exciting, as this year’s first acquisition was already confirmed when Charles ...
Featured in Yahoo Finance: AI Drug Development Investments Accelerated in 2020
MILTON KEYNES, England, Dec. 30, 2020 / -- The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the annual investment value is reaching new heights, the number of funding rounds ...
A New Concept In Market Research
At Emersion Insights, we do things differently. That is why we can offer the highest research quality combined with the most competitive prices in the industry.
By exclusively analysing emerging technology markets with many startups and investors as prospective clients, our magic formula becomes very simple: Produce the highest quality market research that every entrepreneur in the industry would want, and sell this at a price every startup can afford.
Doing so, we achieve maximum impact on the industries we analyse, and we get to spend our time on exciting emerging tech markets at the forefront of the technological and scientific development.
Market Reports
Market Reports on emerging technology markets
Emersion Insights provide syndicated off-the-shelf market reports on emerging technology markets within healthcare and lifesciences.
Our in-depth market intelligence is based on a passion for technology and strategy, and provide robust market sizing, forecast data and strategic insights, only made possible by our connectedness with the industry. Emersion Insights is an integrated part of the startup community. Our market reports are tailored for investors and entrepreneurs, bringing the highest quality data and insights, at a price that fits your budget.
Custom Research
Custom Research on technology and healthcare markets
Do you have unanswered questions that inhibit your growth or strategic planning?
With a decade of experience in the healthtech industry and connections in every corner, we can create a custom project to accommodate your needs and find the answers you are searching for. Our main competencies lie at the intersection of technology, healthcare and lifesciences, and a typical custom project could involve detailed competitor analysis, technology benchmarking, market sizing, trend analysis, business model evolution or go-to-market strategies.
Reach out today to discuss your project, and let’s see what we can do to assist.
Featured In
Meet The Founder
Dr Ulrik Kristensen
Founder & Principal Analyst
After a decade in the healthcare industry, Ulrik decided to follow his passion for new tech and the startup community, and created Emersion Insights to help shape and create the strategies of the world’s innovators.
“Being an integrated part of the startup scene and help new groundbreaking tech get to market faster and better, inspires me to innovate my own thinking and do more for less. Now, it’s all about making a difference for the industries I’m passionate about.”
After a MSc in Molecular Biology from Denmark and a PhD from France, Ulrik spent ten years in the corporate world working at Qiagen and Illumina in scientific roles, and later at Signify Research providing market intelligence services to the world’s largest health tech corporations.
